Broxyquinoline API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Broxyquinoline API 521-74-4?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Broxyquinoline. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Broxyquinoline
- Synonyms:
- Cas Number:
- 521-74-4
- DrugBank number:
- DB13536
- Unique Ingredient Identifier:
- UK4C618C8T
General Description:
Broxyquinoline is a chemical compound identified by the CAS number 521-74-4. It is known for its distinct pharmacological properties and applications.
Classification:
Broxyquinoline belongs to the class of organic compounds known as haloquinolines. These are compounds containing a quinoline moiety, which is substituted at one or more ring positions by n halogen atom, classified under the direct parent group Haloquinolines. This compound is a part of the Organic compounds, falling under the Organoheterocyclic compounds superclass, and categorized within the Quinolines and derivatives class, specifically within the Haloquinolines subclass.
Categories:
Broxyquinoline is categorized under the following therapeutic classes: Alimentary Tract and Metabolism, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics, Heterocyclic Compounds, Fused-Ring, Hydroxyquinoline Derivatives, Hydroxyquinolines, Intestinal Antiinfectives, Quinoline Derivatives, Quinolines. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Broxyquinoline is a type of Antidiarrheals
Antidiarrheals are a category of pharmaceutical active pharmaceutical ingredients (APIs) that are commonly used to treat diarrhea. Diarrhea is a common gastrointestinal disorder characterized by frequent loose or watery stools. It can be caused by various factors, including viral or bacterial infections, food poisoning, medication side effects, or digestive disorders.
Antidiarrheals work by targeting the underlying causes of diarrhea to alleviate symptoms and restore normal bowel function. These APIs can be classified into several subcategories, including opioids, antimotility agents, and adsorbents.
Opioid-based antidiarrheals, such as loperamide, function by slowing down intestinal motility and reducing excessive bowel contractions. By doing so, they help to decrease the frequency and urgency of bowel movements.
Antimotility agents, such as diphenoxylate with atropine, act on the intestinal muscles to inhibit peristalsis, the wave-like movements that propel stool through the intestines. This helps to slow down the passage of stools and allows for more efficient absorption of fluids and electrolytes.
Adsorbent antidiarrheals, like activated charcoal, function by binding to toxins and bacteria in the digestive tract, preventing their absorption and facilitating their elimination from the body.
Overall, antidiarrheals are valuable pharmaceutical APIs that provide relief from diarrhea by addressing its underlying causes. It is important to note that these medications should be used under the guidance of healthcare professionals, as the appropriate choice of antidiarrheal and dosage may vary depending on the specific condition and patient characteristics.
